Valneva Reports H1 2021 Financial Results and Provides Business Update

NEXT STORY
Global Central Nervous System Therapeutics Market, By Drug Class, By Application, By Route of Administration, By End User, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026
PREV STORY
CORRECTING and REPLACING – GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Argos Provides Update on its ADAPT Trial Following Meeting with FDA

DURHAM, N.C., May 10, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News

Emergent BioSolutions to Release Fourth Quarter and Full Year 2015 Financial Results and Conduct a Conference Call on February 25, 2016

GAITHERSBURG, Md., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host ...

author_avatar
NASDAQ Market News

OpGen Data on New Rapid Gene Test and Antibiotic Susceptibility Prediction Algorithms Presented at the 2017 ASM/ESCMID Conference

GAITHERSBURG, Md., Sept. 08, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that ...

author_avatar
NASDAQ Market News